Bacil Pharma

Quarterly
Consolidated
ParticularsJun '26Sep '26
Revenue0.090.09
Expenses0.020.12
EBITDA0.070.03
EBIT0.070.03
Profit Before Tax0.06-0.03
Net Profit-0.02-0.07
Financial Ratios
Operating Profit Margin0.00%0.00%
Net Profit Margin0.00%0.00%
Earning Per Share (Diluted)0.220.06
Dividends Per Share0.000.00